Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCRTR1 | O43613 | 2/20 | 0.41 |
| ▸ | HCRTR2 | O43614 | 2/20 | 0.41 |
| ▸ | NR1H2 | P55055 | 3/20 | 0.41 |
| ▸ | NR1H3 | Q13133 | 3/20 | 0.41 |
| ▸ | CNR1 | P21554 | 1/20 | 0.39 |
| ▸ | CNR2 | P34972 | 1/20 | 0.39 |
| ▸ | GRM5 | P41594 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.38 |
| ▸ | APAF1 | O14727 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | CA12 | O43570 | 4/20 | 0.38 |
| ▸ | CA1 | P00915 | 4/20 | 0.38 |
| ▸ | CA2 | P00918 | 4/20 | 0.38 |
| ▸ | CA4 | P22748 | 4/20 | 0.38 |
| ▸ | CA7 | P43166 | 4/20 | 0.38 |
| ▸ | CA9 | Q16790 | 4/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2193288 | 1.00 | HCRTR1 (0.41) | HCRTR1HCRTR2NR1H2NR1H3CNR1 | |
| SCHEMBL2195252 | 1.00 | HCRTR1 (0.41) | HCRTR1HCRTR2NR1H2NR1H3CNR1 | |
| SCHEMBL2195921 | 0.87 | GRM5 (0.45) | HCRTR1HCRTR2NR1H2NR1H3CNR1 | |
| SCHEMBL2195484 | 0.87 | GRM5 (0.45) | HCRTR1HCRTR2NR1H2NR1H3CNR1 | |
| SCHEMBL2187199 | 0.84 | HCRTR1 (0.43) | HCRTR1HCRTR2NR1H2NR1H3CNR1 | |
| SCHEMBL2192701 | 0.84 | HCRTR1 (0.43) | HCRTR1HCRTR2NR1H2NR1H3CNR1 | |
| SCHEMBL2189550 | 0.84 | HCRTR1 (0.43) | HCRTR1HCRTR2NR1H2NR1H3CNR1 | |
| SCHEMBL2193100 | 0.83 | CNR1 (0.42) | HCRTR1HCRTR2NR1H2NR1H3CNR1 | |
| SCHEMBL7930230 | 0.83 | CNR1 (0.42) | HCRTR1HCRTR2NR1H2NR1H3CNR1 | |
| SCHEMBL2188221 | 0.83 | CNR1 (0.42) | HCRTR1HCRTR2NR1H2NR1H3CNR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2343977-A1 | SUBSTITUTED ARYL SULFONE DERIVATIVES AS CALCIUM CHANNEL BLOCKERS | Merck Sharp & Dohme Corp. (US) | 2011-07-20 | — | — | EP | claimed |
| US-20110172223-A1 | Substituted Aryl Sulfone Derivatives as Calcium Channel Blockers | CHAKRAVARTY PRASUN K | 2011-07-14 | — | — | US | claimed |
| WO-2010036596-A1 | SUBSTITUTED ARYL SULFONE DERIVATIVES AS CALCIUM CHANNEL BLOCKERS | MERCK SHARP & DOHME CORP. (US) | 2010-04-01 | — | — | WO | claimed |
| EP-2343977-A1 | SUBSTITUTED ARYL SULFONE DERIVATIVES AS CALCIUM CHANNEL BLOCKERS | Merck Sharp & Dohme Corp. (US) | 2011-07-20 | — | — | EP | disclosed |
| US-20110172223-A1 | Substituted Aryl Sulfone Derivatives as Calcium Channel Blockers | CHAKRAVARTY PRASUN K | 2011-07-14 | — | — | US | disclosed |
| US-20110172223-A1 | Substituted Aryl Sulfone Derivatives as Calcium Channel Blockers | CHAKRAVARTY PRASUN K | 2011-07-14 | — | — | US | disclosed |
| WO-2010036596-A1 | SUBSTITUTED ARYL SULFONE DERIVATIVES AS CALCIUM CHANNEL BLOCKERS | MERCK SHARP & DOHME CORP. (US) | 2010-04-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110172223-A1 | Substituted Aryl Sulfone Derivatives as Calcium Channel Blockers | TRPV1, TRPA1, CACNA1D | HCRTR1 278/4885HCRTR2 225/4885NR1H2 744/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.